A coalition of over 100 organizations in the Philadelphia region has submitted an $80 million proposal to the government, detailing its strategy for boosting the local life sciences industry. This initiative follows the U.S. Department of Commerce’s designation of Philadelphia as one of 31 federal innovation and technology hubs, with access to up to $500… Read more »
A $100 million, 250,000-square-foot University City life sciences building is about a month away from receiving its temporary certificate of occupancy and the developer is deep in negotiations with potential tenants. The eight-story University Place 3.0 is at 4101 Market St. near several other life sciences and residential projects in development-heavy University City. In addition… Read more »
With Philadelphia’s health sciences industry booming, Drexel University will now house all of its health care programs in one space: a 460,000-square-foot building on 36th and Filbert streets at uCity Square. The new 12-story building, developed by Wexford Science and Technology in collaboration with Drexel and owned by Ventas, will be home to Drexel’s College… Read more »
BioLabs, an incubator for life sciences companies, is expanding its presence in Center City Philadelphia by leasing additional space at Keystone Development + Investment’s mixed-use property The Curtis. Currently occupying 23,378 square feet at the 912,245-square-foot mixed-use property, BioLabs will expand by 30,151 square feet, totaling 53,529 square feet at the property. BioLabs’ new lease will… Read more »
Century Therapeutics Inc. has expanded the amount of space it will occupy at One uCity Square to 90,000 square feet. The fast-growing company initially signed in 2020 to take a single floor totaling 32,500 square feet in the building in the University City neighborhood of Philadelphia. Century will now occupy space across the top three floors of… Read more »
Sterling Bay, Harrison Street and Botanic Properties have entered into a joint venture to buy a 33,400-square-foot land parcel in Philadelphia’s University City neighborhood to develop a 13-story life science facility. The life science facility at 3801 Chestnut St. is set to total 310,000 square feet and feature modern lab space to support the growing needs of… Read more »
One of Philadelphia’s leading gene therapy companies is setting out to build what could be by far the most prominent biomanufacturing facility in the city to date. Spark Therapeutics will build a $575M gene therapy manufacturing facility on what is now a parking lot owned by Drexel University at 30th and Chestnut streets, the company announced Friday. Spark has agreed to… Read more »
